JIANG Xue-chun, PING Fan, ZHANG Jin-feng, et al. Effect of Bixie Chubi Decoction in Preventing and Treating Uric Acid Nephropathy[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(16): 103-108.
DOI:
JIANG Xue-chun, PING Fan, ZHANG Jin-feng, et al. Effect of Bixie Chubi Decoction in Preventing and Treating Uric Acid Nephropathy[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(16): 103-108. DOI: 10.13422/j.cnki.syfjx.2016160103.
Effect of Bixie Chubi Decoction in Preventing and Treating Uric Acid Nephropathy
Objective: To observe the effect of Bixie Chubi decoction (BXCBD) on nuclear transcription factor-κB (NF-κB)
monocyte chemotactic factor-1 (MCP-1)
intercellular adhesion molecule-1 (ICAM-1)
vascular intercellular adhesion molecule-1 (VCAM-1)in renal tissues of rats with uric acid nephropathy
study on regulation of BXCBD on the expression of the above cell inflammatory index
and discuss about the mechanism of BXCBD in preventing and treating uric acid nephropathy renal protection. Method: Adenine (100 mg·kg-1) and ethambutol hydrochloride (250 mg·kg-1) were used to prepare the model of uric acid nephropathy rats. The rats were divided into six groups:normal group
model group
western medicine allopurinol group (5 mg·kg-1)
BXCBD low
medium and high-dose groups (7.25
14.49
29.98 g·kg-1). The rats was sacrificedatthe 21st day.The contents of NF-κB
MCP-1
VCAM-1
ICAM-1 and mRNA in kidney tissues of each group were detected by real-time PCR and Western bolt methods. Meanwhile
NR 8383 macrophages were cultured in vitro
each group wasgiven different concentrations of drug-containing serums
and divided into blank group
model group
traditional Chinese medicine (TCM) low-concentration (2.5%)
middle-concentration (5%) and high-concentration (10%)groups (n=5).NR8383 total cellular proteins were extracted after being cultured for 24 h. Western bolt method was used to detect the expression of the above indicators. Result: According to the in vivo experiment
compared with the normal group
the BXCBD low
medium and high-dose groups showed signficiantly lower NF-κB
MCP-1
ICAM-1 and VCAM-1 protein and mRNA expressions. Compared with allopurinol group
BXCBD low
medium and high-dose groups showed no inter-group statistical difference. On the basis of the in vitro experiment
compared with the model group
BXCBD low
medium and high-dose groups showed lower protein expressions (P<0.05)
particularly middle and high-concentration groups (P<0.01). Conclusion: In vivo and in vitro experiments have confirmed that Bixie Chubi decoction has the effect in preventing and treating uric acid nephropathy.By inhibiting NF-κB
MCP-1
ICAM-1
VCAM-1 in the inflammatory reaction. The mechanism may be related to the reduction of the deposition of uric acid salts.